Powell C C, Schultz S C, Burris D G, Drucker W R, Malcolm D S
Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
Crit Care Med. 1995 May;23(5):867-73. doi: 10.1097/00003246-199505000-00015.
Using a new fluorescence-quenching optode which, unlike earlier oximeters, neither consumes oxygen nor generates heat, we sought to determine the effects of hemorrhage and resuscitation on subcutaneous PO2. Additionally, we compared the effects of resuscitation with diaspirin crosslinked hemoglobin, an oxygen-carrying solution, on subcutaneous PO2 to that of traditional resuscitative fluids. We also compared mean arterial pressure and central venous oxygen saturation, indirect indices of perfusion, to subcutaneous PO2, a direct index of perfusion.
Prospective trial, randomized for selection of treatment regimen.
Shock-trauma laboratory of a medical university.
Male Sprague-Dawley rats, weighing 260 to 380 g.
Rats were bled 22 mL/kg and resuscitated, 1 min later, with either 66 mL/kg of lactated Ringer's solution, 22 mL/kg of human serum albumin, 22 mL/kg of blood, or 22 mL/kg of diaspirin crosslinked hemoglobin. A fifth group of animals was not resuscitated after hemorrhage. Subcutaneous PO2 and mean arterial pressure were monitored continuously throughout the experiment, while central venous oxygen saturation was measured intermittently.
Subcutaneous PO2 decreased in response to hemorrhage and, although it did increase after resuscitation with each fluid, no treatment was able to restore subcutaneous PO2 to baseline within 2 hrs postresuscitation. Subcutaneous PO2 continued to decrease after hemorrhage in the unresuscitated animals. In contrast, mean arterial pressure was restored to baseline values in only blood- and diaspirin crosslinked hemoglobin-treated animals, although this effect was lost within 30 mins in the blood-treated group. Only blood restored the central venous oxygen saturation to baseline values in the early postresuscitation period.
The fluorescence-quenching optode consistently followed changes in subcutaneous PO2 during hemorrhage and after resuscitation. Diaspirin crosslinked hemoglobin performed as well as blood in restoring peripheral perfusion, as measured by subcutaneous PO2, while both of these fluids were superior to either lactated Ringer's solution or albumin. Both whole blood and diaspirin crosslinked hemoglobin restored mean arterial pressure to baseline, although the effect of the latter was of a longer duration. The pressor effect of the crosslinked hemoglobin did not affect peripheral perfusion, as reflected by the values for subcutaneous PO2. Subcutaneous PO2 is a useful adjunct in assessment of the adequacy of peripheral perfusion and may help redefine targets for resuscitation.
使用一种新型荧光猝灭光极,它与早期的血氧计不同,既不消耗氧气也不产生热量,我们试图确定出血和复苏对皮下氧分压(PO2)的影响。此外,我们比较了用双阿司匹林交联血红蛋白(一种携氧溶液)进行复苏与传统复苏液对皮下PO2的影响。我们还比较了平均动脉压和中心静脉血氧饱和度(灌注的间接指标)与皮下PO2(灌注的直接指标)。
前瞻性试验,随机选择治疗方案。
一所医科大学的休克创伤实验室。
体重260至380克的雄性Sprague-Dawley大鼠。
大鼠按22毫升/千克放血,1分钟后,分别用66毫升/千克乳酸林格液、22毫升/千克人血清白蛋白、22毫升/千克血液或22毫升/千克双阿司匹林交联血红蛋白进行复苏。第五组动物出血后未进行复苏。在整个实验过程中持续监测皮下PO2和平均动脉压,同时间歇性测量中心静脉血氧饱和度。
皮下PO2因出血而降低,尽管用每种液体复苏后它确实有所增加,但在复苏后2小时内没有一种治疗方法能够将皮下PO2恢复到基线水平。未复苏动物出血后皮下PO2持续下降。相比之下,只有接受血液和双阿司匹林交联血红蛋白治疗的动物的平均动脉压恢复到基线值,尽管血液治疗组在30分钟内这种效果消失。只有血液在复苏后早期将中心静脉血氧饱和度恢复到基线值。
荧光猝灭光极在出血期间和复苏后始终能跟踪皮下PO2的变化。就通过皮下PO2测量的外周灌注恢复情况而言,双阿司匹林交联血红蛋白的表现与血液一样好,而这两种液体都优于乳酸林格液或白蛋白。全血和双阿司匹林交联血红蛋白都能将平均动脉压恢复到基线,尽管后者的作用持续时间更长。交联血红蛋白的升压作用并未影响外周灌注,这由皮下PO2值反映出来。皮下PO2是评估外周灌注充足性的有用辅助指标,可能有助于重新确定复苏目标。